Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activity.

iScience·2026

Same author

Mechanisms restricting hepatitis B virus cross-species transmission.

mBio·2026

Same author

Protocol for multiplexed detection of antibody binding to cell-surface-expressed hemagglutinin by flow cytometry.

STAR protocols·2026

Same author

Metadomain and metaloop genome interactions in mammalian T cells.

Cell reports·2026

Same author

EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

Nature immunology·2026

Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 18, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

A mouse model for HIV-1 entry.

John Pietzsch¹, Henning Gruell, Stylianos Bournazos

¹Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.

Proceedings of the National Academy of Sciences of the United States of America

|September 29, 2012

Summary

This summary is machine-generated.

New mouse models allow researchers to study how antibodies prevent HIV-1 infection. This research helps in designing effective vaccines by evaluating antibody functions in vivo.

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

A Rat Model of EcoHIV Brain Infection

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Related Experiment Videos

Last Updated: May 18, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

A Rat Model of EcoHIV Brain Infection

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Area of Science:

Immunology
Virology
Genetically Modified Organisms

Background:

Passive transfer of neutralizing antibodies against Human Immunodeficiency Virus type 1 (HIV-1) shows potential in preventing infection and delaying viral rebound.
Evaluating the in vivo efficacy of anti-HIV antibodies is crucial for vaccine development but has been limited by the lack of suitable small animal models.
Understanding the mechanisms of antibody-mediated protection is essential for advancing HIV-1 prevention strategies.

Purpose of the Study:

To develop and validate a genetically humanized mouse model for evaluating the in vivo efficacy of anti-HIV antibodies.
To establish a system for rapid quantitation of HIV-1 entry in vivo using a luciferase reporter.
To systematically assess the factors contributing to an antibody's ability to block HIV-1 viral entry.

Main Methods:

Development of a genetically humanized mouse model incorporating a luciferase reporter system.
In vivo administration of antibodies and subsequent assessment of viral entry.
Quantitation of HIV-1 entry using the luciferase reporter assay to measure antibody efficacy.

Main Results:

The humanized mouse model enables rapid in vivo assessment of antibody-mediated HIV-1 neutralization.
Antibody efficacy in blocking viral entry was found to be dependent on multiple factors, including bioavailability, direct neutralization, and effector functions.
The model provides a platform for systematic evaluation of potential therapeutic and prophylactic antibodies against HIV-1.

Conclusions:

A novel humanized mouse model offers a valuable tool for studying anti-HIV-1 antibody activity in vivo.
The model facilitates a comprehensive understanding of antibody-mediated protection against HIV-1 infection.
This research advances the development of effective antibody-based strategies for HIV-1 prevention and treatment.